Smith & Nephew PLC (SNN) shares plunged 6.84% in the 24-hour period ending in Tuesday's pre-market session, marking a sharp decline for the medical device maker.
The drop occurred after the New York Stock Exchange reported a sell-side order imbalance of 41,040 shares for SNN during the prior session. Such an imbalance indicates that sell orders significantly outweighed buy orders, creating downward pressure on the stock price.
No other company-specific news or broader market catalysts were identified, suggesting the order imbalance was the primary driver of the sell-off.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments